< Back to latest news & events

Event

Microbiome & Probiotic R&D & Business Collaboration Forum: Europe

December 2023

The 12th Microbiome & Probiotics R&D and Business Forum will take place from the 23rd-24th April at the Postillion Convention Centre in the Hague, Netherlands.

This world-renowned event will see three conferences and eight tracks delving into a range of topics such as cutting-edge microbiome, probiotics, and skin-based research.

The event will also cover the challenges and opportunities in translating research towards commercialisation and partnerships and collaborations that secure investment.

HGF Partner Craig Thomson and Trainee Dr Delphine Lauté-Caly will be hosting an insightful roundtable session on‘ Strategic Consideration of your Competitors: an IP perspective.’  View last years agenda here.

For more information, click the button below.

FIND OUT MORE

Attendees

Delphine
Lauté-Caly

Craig
Thomson

Latest updates

Seminar on Incorporating Trade Secrets into your IP Strategy

HGF is hosting a Seminar on Incorporating Trade Secrets into your IP Strategy which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 10th …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

Regulatory Exclusivity for
Medicinal Products in Europe

Video overview: New Medical Products 8 years of data exclusivity, followed by 2 years of market exclusivity. +1 year market exclusivity possible for a new indication showing significant clinical benefit. No exclusivity granted for new formulations or routes of …

Read article

Added Matter - Part 2

Video overview: Pre- and Post-Grant Amendments are governed by Articles 123(2) & 123(3) EPC respectively Before grant, amendments can broaden the claim scope as long as the resulting claim is …

Read article

Added Matter - Part 1

Video overview: What is Added Matter? Added matter occurs when an amendment introduces content that goes beyond what was originally disclosed in the application as filed (Article 123(2) EPC). EPO …

Read article

Patenting Polymorphs at the EPO

Video overview: Novelty and Inventive Step Prior art must necessarily lead to the claimed polymorph to be novelty destroying Watch out for inherent disclosures in prior art—methods may implicitly produce …

Read article

Antibodies

Video overview: EPO Requirements for Antibody Applications The EPO Guidelines (G-II, 6) provide a standardised framework for antibody-related patent issues. Antibodies can be defined by various aspects, including but not …

Read article

Description Amendment Requirements at EPO

Video overview: At the final stage of prosecution, the EPO increasingly insists each patent description must align with the allowed claims to improve clarity and eliminate inconsistencies. However, this strict …

Read article
See all updates